Zee Laboratories Unveils Bold Growth Strategy: Expansion into Global Markets and New Divisions

KARNAL, India - June 24, 2025 - PRLog -- Zee Laboratories, a WHO-GMP certified pharmaceutical company and one of India's fastest-growing pharma innovators, today announced its strategic roadmap for 2025-2026, focusing on global expansion, innovation, and franchise development.

With 22 established divisions across human, veterinary, nutraceutical, and beauty segments, Zee Laboratories aims to deepen its international footprint in regulated and semi-regulated markets including Africa, Southeast Asia, and Latin America. The company is also launching new research-driven divisions in dermatology, critical care, and herbal wellness by the end of FY 2025.

"We're entering a transformative phase. Our mission is to make quality healthcare accessible and affordable globally while empowering entrepreneurs through our franchise model," said Mr. Rajeev Gupta, Director at Zee Laboratories.

Key Highlights of Zee Laboratories' Future Plan:

• International Expansion: Regulatory filings underway in over 10 countries with plans to set up liaison offices abroad.
• New Divisions: Launch of 3 new specialty verticals—Dermaceuticals, Critical Care, and Ayurveda Plus.
• Digital Transformation: Integration of AI-based systems for manufacturing quality assurance and supply chain efficiency.
• Franchise Growth: A strategic focus on expanding the PCD Pharma Franchise network to over 1,000+ partners by 2026.

Zee Laboratories currently operates four state-of-the-art manufacturing units in India with a product portfolio exceeding 2,000 SKUs. Its commitment to quality, innovation, and ethical business practices continues to earn the trust of healthcare professionals worldwide.

For pharma distributors, medical professionals, and global buyers, Zee Laboratories remains a symbol of quality and opportunity.

Media Contact:
Kamlealam
Digital Marketing Executive
📧 marketing@zeelaboratories.com
🌐 www.zeelaboratories.com
📍 Karnal, Haryana, India